Ocugen (OCGN) Liabilities and Shareholders Equity (2014 - 2026)

Ocugen has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $56.9 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 11.72% year-over-year to $56.9 million; the trailing twelve-month figure through Mar 2026 stood at $211.6 million (down 15.15% YoY), and the FY2025 full-year result was $43.5 million, down 47.22% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $56.9 million, up from $43.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $141.7 million in Q1 2022, with the low at $40.5 million in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $78.5 million across 5 years, with a median of $64.5 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 163.2% — and 2024, when it slumped 54.43%.
• Ocugen's Liabilities and Shareholders Equity stood at $108.6 million in 2022, then sank by 40.58% to $64.5 million in 2023, then gained by 27.72% to $82.4 million in 2024, then slumped by 47.22% to $43.5 million in 2025, then jumped by 30.77% to $56.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $56.9 million (Q1 2026), $43.5 million (Q4 2025), and $57.6 million (Q3 2025), per Business Quant data.